Tuberculosis Vaccine Preparedness Repository
Overview
Summary statistics
Home
/
Availability
/
IGRA prevalence study
IGRA prevalence study
Description
A cross-sectional study to determine IGRA positivity rate to assess eligibility for participation in tuberculosis (TB) vaccine efficacy trials
TB vaccine theme
Availability
Epidemiological impact
Project details
Country
Kenya
,
South Africa
Timeline
2024-2025
Target group
Vaccine
Type of protection of vaccine
Type of research
Quantitative
Partners involved
IAVI
Type of project
research
Funder
Civil Society
Governmental Body
Resources
Epidemiology - IAVI
Contact
Puck Pelzer
ppelzer@iavi.org
Click to copy link of this header
Menu
